Alberto Ortiz to Prospective Studies
This is a "connection" page, showing publications Alberto Ortiz has written about Prospective Studies.
Connection Strength
0.100
-
Criteria for classification of protein-energy wasting in dialysis patients: impact on prevalence. Br J Nutr. 2019 06; 121(11):1271-1278.
Score: 0.033
-
The Prevalence of Fabry Disease in Patients with Chronic Kidney Disease in Turkey: The TURKFAB Study. Kidney Blood Press Res. 2016; 41(6):1016-1024.
Score: 0.028
-
Dynamic assessment of interleukin-6 during hemodialysis and mortality in coronavirus disease-19. Ther Apher Dial. 2021 Dec; 25(6):908-916.
Score: 0.009
-
Aspirin for Primary Prevention of Cardiovascular Disease and Renal Disease Progression in Chronic Kidney Disease Patients: a Multicenter Randomized Clinical Trial (AASER Study). Cardiovasc Drugs Ther. 2018 06; 32(3):255-263.
Score: 0.008
-
Influence of dialysis membrane composition on plasma bisphenol A levels during online hemodiafiltration. PLoS One. 2018; 13(3):e0193288.
Score: 0.008
-
Association of FGF-2 Concentrations with Atheroma Progression in Chronic Kidney Disease Patients. Clin J Am Soc Nephrol. 2018 04 06; 13(4):577-584.
Score: 0.008
-
A decrease in intact parathyroid hormone (iPTH) levels is associated with higher mortality in prevalent hemodialysis patients. PLoS One. 2017; 12(3):e0173831.
Score: 0.007